We recently published a list of 9 Stocks Jim Cramer Talked About. In this article, we are going to take a look at where ...

"This type of gene editing should also allow for the treatment of diseases whose origin is not genetic or whose origin cannot ...

with the goal of engineering a decentralized CRISPR-based NAAT solution that can be used by anyone without the need for complex laboratory instruments. We have designed, developed, and validated a ...

Just six years later, after earning a Nobel Prize, CRISPR began to make its way into over 20 clinical trials. The COVID-19 pandemic further demonstrated its potential, with CRISPR-based tests ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Just six years later, after earning a Nobel Prize, CRISPR began to make its way into over 20 clinical trials. The COVID-19 pandemic further demonstrated its potential, with CRISPR-based tests ...

Just six years later, after earning a Nobel Prize, CRISPR began to make its way into over 20 clinical trials. The COVID-19 pandemic further demonstrated its potential, with CRISPR-based tests ...

Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...

For example, when COVID-19 hit, it was hard to diagnose, which we thought was very rate limiting. We got back into the lab—we wore masks and worked in isolated rooms—and we built a detection system ...

She covers the COVID-19 pandemic, new drug developments in cancer and Alzheimer's disease, mental health, HIV, CRISPR, and advances in gene therapy, among other issues in health and science.